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SUMMARY
The health of carers and others close to the patient will often be relevant to economic evaluation, but it is very rarely con-
sidered in practice. This may reﬂect a lack of understanding of how the spillover effect of illness can be appropriately quan-
tiﬁed. In this study we used three different approaches to quantify health spillovers resulting from meningitis. We conducted
a survey of 1218 family networks affected by meningitis and used regression modelling to estimate spillover effects. The
ﬁndings show that meningitis had long-term effects on family members’ health, particularly affecting the likelihood of fam-
ily members reporting anxiety and depression. These effects extended beyond a single close family member. These ﬁndings
suggest that vaccinating against meningitis will bring signiﬁcant health beneﬁts not just to those that might have contracted
the illness but also to their family networks. In methodological terms, different approaches for quantifying health spillovers
provided broadly consistent results. The choice of method will be inﬂuenced by the ease of collecting primary data from
family members in intervention contexts. © 2015 The Authors. Health Economics published by John Wiley & Sons Ltd.
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1. INTRODUCTION
When an individual develops a serious illness, it is likely to be a time of great stress for those close to them. Fam-
ily members may worry and grieve, feel guilt and uncertainty, and undertake increased caring responsibilities.
Consequently, healthcare interventions may improve not only patients’ lives but also the lives of those close
to the patient. These broader beneﬁts of healthcare may include health beneﬁts for the patient’s family. Health
beneﬁts may stem from family members’ reduced anxiety or from freeing them from physically draining caring
responsibilities (Christakis and Iwashyna, 2003, Pinquart and Sorensen, 2003, Bobinac et al., 2011). Despite
many calls for these wider health beneﬁts (which we term ‘health spillovers’ in this paper) to be considered in
economic evaluations (Brouwer et al., 1999, Al-Janabi et al., 2011, National Institute for Health and Care Ex-
cellence (NICE), 2013, Gold et al., 1996), they are almost always ignored (Goodrich et al., 2012). In part, this
is likely to reﬂect a lack of awareness of how health spillovers can be quantiﬁed for economic evaluation.
Formal consideration of health spillovers in economic evaluation has been advocated for some time. The 1996
US Panel on Cost-Effectiveness suggested that “In a CEA…all health effects that ﬂow from it [the intervention] are
counted. Health effects include both beneﬁts and harms, even when these occur in people who are not the intended
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recipients of the intervention.” (Gold et al., 1996). In their latest guidance, the UK’s National Institute for Health
and Care Excellence also highlights the relevance of health spillovers, commenting that economic evaluations
should consider: “…all direct health effects, whether for patients or, when relevant, carers” (NICE, 2013).
Consideration of health spillovers is needed to understand the total health beneﬁts of healthcare interventions.
Furthermore, health spillovers matter in practice, as inference about the most cost-effective treatment strategy
can rest on whether health spillovers are considered (Bilcke et al., 2009, Krol et al., 2015).
In health economics, much of the attention on spillover effects has focused on the wider welfare (as opposed
to ‘health’) impacts of healthcare consumption. Early work by Culyer (Culyer, 1989, Culyer and Simpson,
1980, Culyer, 1971) showed how healthcare consumption could generate welfare gains (‘caring externalities’)
for others in society. Subsequent empirical work has shown that caring externalities extend widely in scope
(Jacobsson et al., 2005) and can be large in magnitude (Drummond et al., 1991, Basu et al., 2010, Hurley
and Mentzakis, 2013, Prosser et al., 2004). Some authors have proposed conceptual frameworks to take these
wider welfare effects into account in economic evaluation (Basu and Meltzer, 2005).
Yet it is a narrower interpretation of health spillover that is relevant to most applied economic evalua-
tions. In practice, the focus is usually on maximising some measure of health output (often quality-adjusted
life years (QALYs)) rather than welfare per se (Brouwer et al., 2008, Coast et al., 2008, Drummond et al.,
2005). Although health maximisation rules-out wider welfare effects, it rules-in wider health effects. A
review of perspectives taken in economic evaluation highlights that health effects on carers are relevant to
consider, when maximising health, whether one takes a societal or a healthcare perspective to the economic
evaluation (Claxton et al., 2010).
There is a growing literature on the wider health effects of illness. This research demonstrates, for example,
that many health conditions affect the health status of close family members. For example, studies have shown
that patient disabilities affect family members’ health status across a range of childhood conditions (Tilford
et al., 2005, Poley et al., 2012, Yamazaki et al., 2005, Wittenberg et al., 2013) and adult conditions (Davidson
et al., 2008, Peters et al., 2011, Gallagher and Mechanic, 1996, Coe and Van Houtven, 2009). There is also a
wide literature that shows that informal carers’ health suffers, as the degree of disability and needs of the patient
increases (Brouwer et al., 2004, Argimon et al., 2004, Bobinac et al., 2011). These studies strongly suggest that
healthcare interventions that treat a patient’s illness would have health spillover beneﬁts to their close family
members. However, there are two gaps which need addressing to incorporate such evidence in economic eval-
uation. First, it is not obvious how the health spillover beneﬁts of interventions can be quantiﬁed for use in eco-
nomic evaluation. Second, the focus of existing research is mainly on the patient’s family caregiver, and it is
not clear whether there is a need to consider health beneﬁts beyond a single close family member.
The research reported here aimed to address these gaps. We used a case study of meningitis vaccination to
illustrate how health spillovers could be quantiﬁed for use in economic evaluation. Our speciﬁc objectives were
to (i) identify whether health spillovers were likely to result from vaccination against meningitis; (ii) establish
whether the spillover effect extends to multiple family members of the same patient; and (iii) compare methods
for quantifying health spillovers for consideration in economic evaluation.
2. MENINGITIS CASE STUDY
Meningitis is an acute, potentially life-threatening infection of the membranes surrounding the brain and spine.
It is most common in very young children, although it can be contracted at any age. Mortality during the acute
phase varies by cause, age, and country with around 2–11% of people affected dying in the UK (Visintin et al.,
2010). Survivors often make a full recovery from the infection, but evidence suggests that around 20% of in-
dividuals who contract bacterial meningitis develop one or more after-effects (Viner et al., 2012, Edmond et al.,
2010). These after-effects include cognitive problems, seizures, hearing loss, motor limitations, amputations,
vision problems, and behavioural problems. The after-effects are not only likely to impact on the lives of the
survivors but also, through the potential stress, additional care requirements, and changes in behaviours (such
H. AL-JANABI ET AL.
© 2015 The Authors. Health Economics published by John Wiley & Sons Ltd. Health Econ. (2015)
DOI: 10.1002/hec
as self-care and healthcare use) on the lives of their close family members. We have outlined a simple diagram
showing the potential scope of health effects arising from the disabling after-effects of meningitis (Figure 1).
Many causes of meningitis can be largely prevented by vaccination. Vaccination saves lives, but a major
beneﬁt is also that it prevents individuals contracting meningitis and living a lifetime with the disabling
after-effects of the illness. Thus vaccination would shift many potential patients and their families from the ﬁrst
pathway in Figure 1 to the second pathway (prevention). Some causes of meningitis, notably ‘MenB’, have
proved difﬁcult to vaccinate against, although promising vaccines have recently been developed. From a policy
perspective, it is important to know whether new vaccines are cost-effective, and this requires a calculation of
the likely health beneﬁts. If health beneﬁts are likely to accrue, not just to potential patients but also to their
family members, then this may be relevant to decision-makers.
Figure 1. Framework for examining health spillovers arising from the prevention of meningitis
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3. METHODS
3.1. General approach
To examine the presence of health spillovers arising from the long-term effects of meningitis, we conducted a
prospective survey of families affected by meningitis. This survey provided data on the health outcomes of sur-
vivors and their close family members. We then used three methods to quantify the scale of health spillovers
arising from the long-term after-effects of meningitis.
Method 1 uses a comparison group to identify the health decrement associated with after-effects. The spill-
over effect is the difference in health status between family members in the group ‘exposed’ to after-effects and
family members in the comparison group. In our study the comparison group was family members who were
not exposed to the long-term after-effects of meningitis.
Method 2 uses regression analysis to express a family member’s health status as a function of the survivor’s
health status. The spillover effect is given by the coefﬁcient on variable(s) representing the survivor’s health
status. This provides an estimate of what we term the ‘relative’ spillover effect, as it shows the change in an
average family member’s health status relative to a change in the survivor’s health status.
Method 3 is an extension of the regression-based approach employed in Method 2, to explicitly examine the
spillovers in a survivor’s wider family network. To examine these wider spillovers we collected data from mul-
tiple members of the same family network. Separate regression analyses were conducted in different groups of
family members, and the ﬁndings used to provide estimates of what we term the ‘aggregate’ spillover effect.
3.2. Data collection: ‘family impact of meningitis study’
We identiﬁed family members of people affected by meningitis from the membership records of a large men-
ingitis1 charity (Meningitis Research Foundation (MRF)) in the UK. Family members were included if they
were 13 years old or over, and were excluded if they had contracted meningitis themselves, were not close
to someone who had contracted meningitis, or if the person affected by meningitis had died.
We developed a survey questionnaire for family members to complete2 and reﬁned the questionnaire content
using a qualitative focus group (n=6) and small postal pilot (n=30) with MRF members. In the questionnaire,
the health status of family members and survivors was measured using the EQ-5D-5L (Herdman et al., 2011),
the generic health status tool advocated by National Institute for Health and Care Excellence (NICE) for calcu-
lating QALYs (NICE, 2013). Family members reported the health status and the presence of any long-term
after-effects from meningitis for the survivors. Proxy reports were necessary because of the large number of
survivors that would be unable to self-report their health because of their age or disability. In addition, we in-
cluded a number of questions about the meningitis infection and socio-demographic circumstances.
Our sample size was based on previous studies of the association between patient and carer health status
(Bobinac et al., 2011, Tilford et al., 2005). These studies indicated that a relative spillover effect of 0.1 in fam-
ily member health status in a regression model was plausible. To detect such an effect with 80% probability at
p=0.05 required at least 787 respondents. Assuming a response rate to the survey of 25%, we needed an initial
sample frame of 3148 members. From the MRF database, we identiﬁed 3417 potentially eligible members.
Rather than exclude 269 members, all members were included. Questionnaires were included in a survey pack
with information about the study and a pre-paid reply envelope and posted to all eligible members of the MRF
in May 2012.
To investigate whether spillovers were present in multiple members of the same family network, we sent
two questionnaires to each member. The named recipient was asked to complete the ﬁrst questionnaire and pass
the second questionnaire on to a second person close to the survivor. A reminder postcard was sent to all
1Septicaemia was included as well as both conditions can co-exist and be prevented through vaccination. For brevity, and in view of the
small number of cases that were solely septicaemia, we use ‘meningitis’ to refer to both.
2In this study we describe all respondents as ‘family members’, although a very small proportion were in fact close friends.
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members after one week, and a reminder letter was sent to all non-responders after four weeks. We entered data
into a secure database, with 5% of questionnaires being double entered to verify the accuracy of data entry. The
study protocol was approved by the University of Birmingham’s Life and Health Sciences Ethical Review
Committee (ERN_11-0191).
3.3. Estimating the absolute health spillover effect on family members (Method 1)
We split family members into those exposed to after-effects and those who were unexposed to examine whether
family members’ health status was inﬂuenced by the after-effects of meningitis. We used survey responses to
determine whether family members were exposed to one or more of 20 possible after-effects. Pre-speciﬁed
after-effects were determined by literature (Edmond et al., 2010) discussion with experts, and the aforemen-
tioned focus group with MRF members. Additionally a number of family members reported the presence of
after-effects that were not covered by the list. These additional after-effects were reviewed for plausibility by
three of us (two of whom have expertise in the epidemiology of meningitis) and individually coded for inclu-
sion or exclusion. Family members were included in the exposed group if they recorded the survivor as having
one or more long-term after-effects from meningitis.
To estimate family members’ health status on a 0 (death) to 1 (full health) scale, responses to the EQ-5D-5L
questionnaire were scored using interim value sets for the UK (Van Hout et al., 2012). T-statistics were used to
identify whether the health status (EQ-5D-5L) of family members exposed to after-effects differed from those
who were not exposed. We used univariable logistic regressions to identify whether family members were more
likely to report any problems (as opposed to no problems) in the individual domains of the EQ-5D-5L in the
presence of after-effects in the survivors. To set these ﬁndings in context, we repeated the analysis to examine
how survivors themselves were affected by the after-effects of meningitis.
3.4. Estimating the relative health spillover effect on family members (Method 2)
To estimate the relative spillover effect we modelled the health status of family members as a function of the
health status of survivors, controlling for other contextual factors. We adapted the approach used by Bobinac
et al. to estimate spillover effects on informal carers (Bobinac et al., 2010, Bobinac et al., 2011), by expressing
the health status of family members (Hf) as Hf= f(Hp, Xf, Xp, C) where Hp is the health status of patients
(survivors), Xf is a vector of characteristics of the family member, Xp is a vector of characteristics of the survi-
vor, and C is a vector of contextual characteristics. When this model is estimated through regression analysis,
the coefﬁcient on the Hp variable provides the relative health spillover effect.
3 In the rest of the paper, we refer
to this coefﬁcient as the ‘spillover coefﬁcient’.
In the regression models, the health status of the family members (Hf, dependent variable) and survivors (Hp,
independent variable) was measured using EQ-5D-5L index scores. We attempted to control for other factors
that could affect family member and survivor health status and thus confound any true spillover effect (Manski,
1993). In terms of socio-demographic characteristics, we controlled for the family member’s age, sex, educa-
tion level and employment status, and survivor’s age and sex. We additionally controlled for a number of
contextual factors that may inﬂuence both family member and survivor health status. These were (i) the time
elapsed since the initial infection, as both survivor and family member may adapt to the effects of the menin-
gitis; (ii) the presence of a biological relationship, as both may have a genetic predisposition to poor/good
health; (iii) co-residence, as there may be contemporaneous environmental exposures; and (iv) the number of
people in the family member’s household, as the health of both groups may be affected by common social sup-
port networks. The regression models were estimated in the sub-sample of family members exposed to after-
3It is important to note that we are focusing on spillover effects as associations between the health changes in survivors and their family
members. We do not seek to demonstrate, nor require, that causality runs solely from patient health status to family member health status.
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effects of meningitis. Analyses were conducted including individuals with complete data across all variables
considered for the regression modelling.
We checked that a signiﬁcant spillover effect was not simply an artefact of the fact that family members re-
ported the survivor’s health status as well as their own. To do this we used data from family networks with two
family members responding. We replaced the ﬁrst family member’s proxy report of survivor health status with
the second family member’s proxy report (and vice versa). We compared the signiﬁcance and magnitude of the
spillover coefﬁcient when independent ratings of survivor health status were used, with the spillover coefﬁcient
when non-independent ratings of survivor health status were used.
In common with other studies of health spillovers (Coe and Van Houtven, 2009, Bobinac et al., 2011,
Bobinac et al., 2010, Tilford et al., 2005) all regression models were estimated using ordinary least squares re-
gression. We initially ran a univariable regression (of Hf on Hp) and then introduced family member character-
istics, survivor characteristics, and contextual characteristics sequentially into the regression model to examine
what, if any, impact this had on the signiﬁcance and magnitude of the spillover coefﬁcient. Data analysis was
conducted using Stata v12. Standard errors in the regression models were adjusted for clustering of the obser-
vations at the family level. Non-linear relationships between the dependent variable and the four continuous
independent variables in the model (family member health status, survivor age, family member age, and time
elapsed since infection) were explored using graphical and statistical methods. The Ramsey Regression Equa-
tion Speciﬁcation Error Test (RESET) test was used to identify mis-speciﬁcation of the functional form of the
variables.
3.5. Estimating the aggregate health spillover effect (Method 3)
To examine whether spillovers were present only in closest family members, we examined the presence of
spillovers in family networks where two family members responded. We ﬁrst re-estimated the regression model
in the sub-sample of family members deemed closest4 and then in the sample of family members deemed
second closest. We took a signiﬁcant spillover coefﬁcient in the second regression model to indicate spillover
effects that extended beyond the closest family network member. We used the same speciﬁcations for the re-
gression models as previously.
We also re-ran the regression models within speciﬁc groups of family members (parents, partners, grandpar-
ents, children, and siblings) as an alternative way of examining the potential for multiple spillovers within a
family network. The sign, signiﬁcance, and magnitude of the spillover coefﬁcients were used to check whether
the health status of different groups of relatives were associated with the health status of the survivors.
4. RESULTS
4.1. Survey response
Figure 2 displays the response to the survey and the number of family members included at each stage of the
analysis. Thirty-seven per cent of households contacted responded to the survey, 97% of whom were eligible to
be included. The most common reason for ineligibility was that the person affected by meningitis had died, and
the most common reason cited for non-participation was that the meningitis episode was too long ago. Thirty-
one per cent of the responding households provided responses from two family members. In total, there were
responses from 1587 eligible family members of 1218 survivors.
4As there is not an established way of assessing the closest person in a family network, we used the data collected on co-residence, social
contact, relationship, and employment status to try to classify which family member could be deemed ‘closer’ to the survivor. We deﬁned
the closer family member as the one who was co-resident or reported more social contact with the survivor. If family members tied on these
criteria we classiﬁed the family member as closer if they were a closer relation or reported a lower level of employment (potentially indi-
cating more time at home with the survivor). Some parents tied on all criteria. In these cases we classiﬁed mothers as closer than fathers
(Mallers et al., 2010)).
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The sample of the respondents (‘whole sample’; Table I) comprised a majority of female respondents. Most
respondents were parents of the survivors (76%, n=1192) although a number of partners (6%, n=102) and
grandparents (9%, n=137) responded. The initial meningitis infection occurred an average of 12 years ago,
and survivors were now aged 23 years old on average.
4.2. Impact of after-effects on family members’ health status
Sixty-seven per cent (n=1053) of family members reported at least one after-effect from meningitis in the sur-
vivor. The most commonly reported after-effects were behavioural or emotional problems (28%),
mild/moderate learning disabilities (16%), scarring or tissue damage (14%), balance problems (13%), and
speech or language problems (11%).
The presence of after-effects in survivors was associated with lower health status for family members. The
mean difference in EQ-5D-5L scores between exposed family network members and controls was 0.041 (95%
CI: 0.024 to 0.058) (Table II). Further analysis (available on request) shows that this decrement is fairly con-
stant with respect to time since the initial infection. This suggests that for the purposes of economic evaluations,
it may be reasonable to interpret the 0.041 ﬁgure as an annual QALY decrement for close family members.
Figure 2. Response to the survey and inclusion at different stages of the analysis
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Family members exposed to the after-effects of meningitis had 2.3 (95% CI: 1.8 to 2.9) times higher odds of
reporting anxiety or depression, 1.4 (95% CI: 1.0 to 2.0) times higher odds of problems with usual activities,
and 1.3 (95% CI: 1.0 to 1.6) times higher odds of pain or discomfort compared with family members of survi-
vors without after-effects. The health status of survivors with after-effects from meningitis was signiﬁcantly
worse than those without after-effects with a mean difference in EQ-5D-5L between the two groups of 0.19
(95% CI: 0.17–0.22)).
4.3. The relative health spillover effect on family members
Regression models to estimate the spillover coefﬁcient were estimated using 901 out of the 1053 family mem-
bers close to someone with after-effects (Table III). The model estimations indicate a positive spillover coefﬁ-
cient of 0.16 (p< 0.001). The direction, statistical signiﬁcance and magnitude of the spillover coefﬁcient was
unaffected by the introduction of variables to control for characteristics of the family member, survivor, or ill-
ness context (model 1 and model 2). Model 2 indicates that in addition to being positively associated with
Table I. Descriptive statistics of the participants in the study
Characteristic Whole sample (n = 1587) Regression sub-sample (n = 901)
Family member
Sex (female, %) 74% 77%
Age (years, mean (SD)) 51 (13) 50 (12)
Health status (EQ-5D-5L, mean (SD)) 0.88 (0.16) 0.88 (0.16)
Education (degree, %) 43% 41%
Employment (full-time, %) 35% 35%
Survivor
Sex (female, %) 46% 46%
Age (years, mean (SD)) 23 (16) 24 (17)
Health status (EQ-5D-5L, mean (SD)) 0.84 (0.26) 0.77 (0.27)
After-effects reported (%) 67% 100%
Time since infection (years, mean (SD)) 12 (7) 12 (8)
Context
Biological relation (%) 92% 91%
Co-resident (yes, %) 61% 65%
Adults in house (mean) 2.27 2.26
Children in house (mean) 0.98 0.98
Table II. A comparison of the health status of the family members and survivors exposed to after-effects of meningitis
compared with those who were unexposed
Characteristic Exposed (n = 1053) Unexposed (n = 517)
Family member
Health status (EQ-5D-5L, mean) 0.87*** 0.91
Mobility problems (%) 14% 13%
Self-care problems (%) 3% 2%
Usual activities problems (%) 14%* 10%
Pain/discomfort problems (%) 33%* 27%
Anxiety/depression (%) 40%*** 23%
Survivor
Health status (EQ-5D-5L, mean) 0.78*** 0.97
Mobility problems (%) 24%*** 1%
Self-care problems (%) 19%*** 1%
Usual activities problems (%) 37%*** 3%
Pain/discomfort problems (%) 38%*** 4%
Anxiety/depression (%) 46%*** 9%
*p< 0.05, **p< 0.01, ***p< 0.001.
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survivor health status, family member health status was positively associated with the family member being
male, young, employed, biologically related to the survivor, and close to survivor who was male, older, and
had a more recent infection. Investigations of the presence of non-linear relationships between the independent
variables and the dependent variable provided no evidence for including non-linear terms in the regression
model. Ramsey RESET tests showed no mis-speciﬁcation.
The effect of re-estimating the regression model using independent ratings of the survivors’ health status is
shown in Table IV. The positive and statistically signiﬁcant spillover coefﬁcient remained when independent
Table III. Regression model estimates of the relative spillover effect on family members’ health status (n= 901)
Variables Model 1 (univariable) Model 2 (multivariable)
Survivor
Health status (EQ-5D-5L) 0.16*** 0.16***
Sex (male) - 0.025*
Age (years) - 0.0011**
Time since infection (years) - 0.0018*
Family member
Sex (male) - 0.032*
Age (years) - 0.0019***
Education
16 - 0.023
18 - 0.033
Degree - 0.041
Employment (full-time) - 0.031**
Context
Non-biological relation - 0.049*
Co-resident - 0.0085
Adults sharing house - 0.0096
Children sharing house - 0.010
R2 = 0.072 R2 = 0.163
*p< 0.05, **p< 0.01, ***p< 0.001.
Table IV. Robustness test of regression modelling using independent proxy ratings of survivors’ health status
Variables Model 3 (independent proxy) Model 4 (base case)
Survivor
Health status (EQ-5D-5L) 0.16*** 0.17***
Sex (male) 0.0055 0.0061
Age (years) 0.00072 0.00071
Time since infection (years) 0.0025* 0.0025*
Family member
Sex (male) 0.016 0.0016
Age (years) 0.0014 0.0014
Education
16 0.016 0.0095
18 0.0012 0.0016
Degree 0.0011 0.0014
Employment (full-time) 0.038* 0.036*
Context
Non-biological relation 0.044 0.041
Co-resident 0.0019 0.0019
Adults sharing house 0.0093 0.0083
Children sharing house 0.019* 0.019*
R2 0.206 0.211
Observations 326 326
Note: Individuals are included in this analysis only if they are from dual family networks where both family members provided full data
across all relevant variables.
*p< 0.05, **p< 0.01, ***p< 0.001.
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ratings of survivor health status were used (model 3). This suggested that using the same individuals to rate
their own health status and the survivor’s health status did not appear to bias the results (i.e. model 3 and model
4 provide identical estimates of the spillover coefﬁcient).
4.4. Aggregate health spillovers
Three hundred sixty-two respondents from family networks with two respondents provided full data across all
variables considered in the regression model. These respondents were allocated to be in either the sub-sample
of closest (n=184) or second closest (n=178) family members. The spillover coefﬁcient in the ﬁrst sample
(closest family members) was 0.18 (95% CI: 0.10 to 0.27), and in the second sample (second closest family
member) it was 0.11 (95% CI: 0.04 to 0.18) (Table V). Model 6 indicates the presence of a statistically signif-
icant effect on the second closest family members and therefore that health spillovers may extend to more than
one close family member. The lower spillover coefﬁcient in model 6 (0.11) relative to model 5 (0.18) suggests
that the spillover effect declines with increasing social distance from the survivor.
Regression models run within speciﬁc groups of family members suggested that different family relations
may be affected by the after-effects of meningitis. The spillover coefﬁcient was positive and signiﬁcant
(p<0.05) for parents (0.14), siblings (0.35), and partners (0.24) (Table VI). In this sample, spillover coefﬁ-
cients within sub-samples of grandparents and children of the survivors were non-signiﬁcant at the 5% level.
5. DISCUSSION
This study illustrates how health spillovers can be measured for use in economic evaluation. Using a case study
in meningitis, we found that long-term morbidity from meningitis resulted in health losses to survivors’ family
members (in addition to the survivors themselves). This implies that there will be spillover beneﬁts from vac-
cinating against meningitis for patients’ family networks. These health spillovers were quantiﬁed in different
ways. The absolute beneﬁt of avoiding long-term morbidity in a survivor was estimated to be 0.041 QALYs
per close family member, per year. Regression modelling showed that, on average, family member health status
Table V. Estimation of the relative spillover effect in closest and second closest family members
Variables Model 5 (closest family member) Model 6 (second closest family member)
Survivor
Health status (EQ-5D-5L) 0.18*** 0.11**
Sex (male) 0.025 0.016
Age (years) 0.00093 0.0013
Time since infection (years) 0.0025 0.0036*
Family member
Sex (male) 0.0050 0.031
Age (years) 0.0022 0.00058
Education
16 0.0092 0.047
18 0.017 -0.029
Degree 0.025 -0.032
Employment (full-time) 0.024 0.041
Context
Non-biological relation 0.048 0.012
Co-resident -0.031 0.032
Adults sharing house -0.032 0.012
Children sharing house 0.0039 0.026*
R2 0.168 0.173
Observations 184 178
*p< 0.05, **p< 0.01, ***p< 0.001.
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would change by 16% of the change in survivor health status. We found that spillover effects were also likely to
extend beyond the closest family members. Later in this section we discuss how these different spillover esti-
mates could be incorporated within an economic evaluation.
The magnitude of the spillovers estimated in our study is consistent with ﬁndings from some other studies
(Bobinac et al., 2011, Tilford et al., 2005). However, spillovers are unlikely to be consistent across contexts. A
recent review suggests substantial variation in the likelihood of spillover by context (Wittenberg and Prosser,
2013). Recent evidence indicates that spillover impacts are likely to be greatest when dealing with childhood
and mental health conditions (Wittenberg et al., 2013, Lavelle et al., 2014). As many of the survivors in this study
were children with psychological problems, it seems likely that our spillover estimates would be at the higher end
of the spectrum. In terms of the magnitude of the spillover, a 0.041 difference on the EQ-5D-5L is in line with
reported minimally important differences in preference-based measures of health status (Luo et al., 2010). Further-
more, as noted in the results, the spillover effect is likely to persist for many years after the initial infection. The
total health spillover, in terms of QALYs per family member, is therefore likely to be much greater.
Our ﬁnding that spillovers extend beyond the closest family member and decline with increased social dis-
tance is consistent with research on social networks. This literature suggests that many health-related phenom-
ena spread in social networks (Christakis and Fowler, 2013). Studies show that the ‘force’ of the spread
declines with social distance from the central individual in the study (Christakis and Fowler, 2013). We found
that the after-effects of meningitis appear to have ‘contagious’ negative effects on family members’ health sta-
tus. As vaccination would remove the source of the contagion, vaccination would generate health beneﬁts that
extend beyond the immediate beneﬁciaries. At ﬁrst glance it might seem surprising that health beneﬁts to close
family members would potentially exceed 29%5 of the direct beneﬁt to patients themselves, given the debilitat-
ing impact of after-effects on the lives of the survivors. But, it is important to note that the scale of health
spillovers is a product of both the impact on family members and the number of family members affected.
Thus, when effects on individual family members are aggregated over the wider family network they may
become quite large. Furthermore, this study focuses on spillovers in terms of family members’ health status.
If spillovers also occur in terms of, for example, families’ labour force participation, child-rearing decisions,
and social activities, the total effect on families will be greater than estimated here.
We used three approaches to quantify health spillovers. The ‘absolute spillover’ approach (Sections 3.3 and
4.2) is likely to work best when outcome data can be collected as part of a controlled trial of the intervention of
interest. Trials would allow direct evidence of the effect of the intervention on family members to be collected
alongside evidence of the effect on patients. The ‘relative spillover’ approach (see Sections 3.4 and 4.3), on the
other hand, is more suited to contexts where data on the effect of the intervention on family members cannot be
collected, for example, because a trial is not feasible for resource, ethical or practical reasons. In this case, ob-
servational data may be used to model the degree to which changes in patient health may spillover to affect the
health status of close family members. Finally, an estimation of the aggregate spillover (see Sections 3.5 and
5i.e. 18% in the closest family member (based on the 0.18 spillover coefﬁcient) and then 11% in the second closet family member (based on
the 11% spillover coefﬁcient).
Table VI. Regression estimates of the spillover coefﬁcients by relation to survivor
Regression sample Spillover coefﬁcient
Model 7: parents (n = 692) 0.14***
Model 8: siblings (n = 31) 0.36*
Model 9: partners (n = 72) 0.24***
Model 10: grandparents (n = 59) 0.14
Model 11: children (n = 31) 0.05
Other relations are omitted because of the small number (<10) of observations.
All regression models are adjusted for the potential confounding variables outlined in Model 2
(Table III).
*p< 0.05, **p< 0.01, ***p< 0.001.
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4.4) to the whole family network may be the most desirable, in theory. However, it will be challenging to ag-
gregate spillover effects across the family with precision. In practice, characterising the total health beneﬁts
from interventions is likely to require a mixture of primary research and modelling work. In the absence of pri-
mary data on the health status of family members, it may be possible to draw on ﬁndings from related clinical
trials or large-scale datasets that have linked data on patient and family member health status. However, it is
important to bear in mind that spillover effects are likely to be context-speciﬁc and that direct measurement
within the speciﬁc context of the research is likely to be the best solution.
In Table VII, we illustrate how the spillover estimates could be used to inform economic evaluation.6
The estimates of spillover health beneﬁts (and hence total health beneﬁts) are quite sensitive to assump-
tions made about the number of family members affected. However, the different methods for measuring
health spillovers do result in similar conclusions. For example, the absolute spillover effect (0.041
QALYs per year) and relative spillover effect (16%) are broadly consistent with one another, when
one considers that 16% of the annual QALY effect on survivors (0.19 QALYs) is 0.03 QALYs. It
should be noted that this study focuses on measurement issues if these estimates are included in eco-
nomic evaluation, they would need to be discounted in line with the assumption adopted in the economic
evaluation.
This is the ﬁrst study to compare methods for measuring health spillovers for use in economic evaluation.
However, there are some limitations that are worth noting. First, we used family members’ proxy reports of sur-
vivors’ health status. Evidence suggests that parents may be reliable reporters of physical limitations in chil-
dren, but their ability to report more subjective outcomes is more limited (Ungar, 2011). As noted earlier,
proxy ratings of survivor health status were used for practical reasons and did not introduce bias in terms of
the size of the spillover coefﬁcients. Nevertheless, it would be interesting to see if the ﬁndings of this study
would be replicated with patients that reported their own health status. Second, our categorisation of family
members as closest and second closest used pragmatic criteria we developed based on the data collected in
the study. Using other criteria, for example, bespoke instruments to measure family attachment, may well have
resulted in a slightly different categorisation. Third, in the regression models, we attempted to control for the
factors that could confound the relationship between the health status of family members and survivors.
However, there may have been environmental factors, affecting both the health of survivors and family
members, which we were not able to control for. It is important to note however that we purposefully avoided
variables relating to informal care, as these may be on the causal pathway between the patient’s health status
and the family member’s health status. Therefore, including such variables is likely to diminish the measured
spillover effect.
There are a number of areas where further research is needed. We still know little about the scope of family
impacts from healthcare interventions. The ﬁndings from this study suggest that spillover effects on two close
family members are likely. However, the social network literature suggests that spillover effects may well
spread more widely. Further use of ‘ecomaps’ (Rempel et al., 2007), to depict patients’ close family network,
may be a useful way of identifying the scope of family impact prior to empirical work. The normative frame-
work for considering health spillovers also requires consideration. Inclusion of health spillovers will most
likely, although not always, inﬂate beneﬁt estimates and therefore make interventions appear more cost-
effective (Goodrich et al., 2012). Consequently, inclusion of spillover effects in cost-effectiveness evaluations
will potentially draw resources towards treatments for illness that have a higher impact on carers and family
members and away from illnesses that affect only the patient. This may have important equity implications
(Basu and Meltzer, 2005). Therefore, a sensible starting position might be to present spillover beneﬁts along-
side patient beneﬁts, as well as in aggregated form, within an economic evaluation (Brouwer et al., 1999,
6Indeed a recent study has already used preliminary data on the sensitivity of family QALYs to patient health status to incorporate family
health in their modelling of the cost-effectiveness of vaccination against MenB (Christensen et al., 2014)
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Goodrich et al., 2012). This would enable policy-makers to incorporate such information in decision-making in
a way they felt was appropriate.
This study demonstrates that sizeable health spillovers, which extend beyond the closest family member, are
likely to occur in the context of preventing meningitis. From a methodological perspective, different ap-
proaches for quantifying health spillovers provided broadly consistent results. The choice of method will be
inﬂuenced by the ease of collecting primary data from family members in intervention contexts. To align eco-
nomic evaluation with improving population, as opposed to purely patient health, it is important that health
spillovers are given attention in applied economic evaluation.
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